Concentra makes bid for struggling biotech Rain
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Robert Doebele. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The late-stage precision oncology company said it would lay off 65% of its workforce and halt the launch of a Phase 1/2 MANTRA-4 combination trial.
Operator: Greetings, and welcome to the Rain Oncology, Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Operator: Greetings, and welcome to the Rain Therapeutics Third Quarter Earnings Conference Call. At this time all participants are in a listen-only mode.